Mass Device Organovo (PINK:ONVO) today announced it is developing 3D bioprinted human liver tissue designed for direct transplantation to patients. The move to human development comes based on “strong results” from preclinical animal model studies, the San Diego … Organovo to make liver tissue for transplant; Meeting on the Mesa beginsThe San Diego Union-Tribune Organovo Plans to Develop 3D Bioprinted Human Liver for Transplant3DPrint.com
top of page
Search
Recent Posts
See AllAction Points Note that this study was published as an abstract and presented at a conference. These data and conclusions should be...
130
Genomic Signature for Predicting Acute Rejection in Liver Transplant Patients to be Presented at the
CHICAGO, May 1, 2017 /PRNewswire/ — Dr. Josh Levitsky, Professor of Medicine (Gastroenterology, Hepatology) and Surgery (Organ...
70
New anti-rejection drug reduces weight gain, enhances outcomes for liver transplant recipients ̵
Researchers have discovered that a new anti-rejection drug that is gentler on the kidneys after liver transplant also reduces weight...
160
bottom of page
Comments